In mice models of primary obesity and type 2 diabetes, a 16-week ADF intervention significantly reduced blood glucose levels and preserved pancreatic β-cell function by modulating the hepatic AMPK/mTOR axis, thus effectively countering insulin resistance [40]. The gene discussed is INS; the disease is type 2 diabetes mellitus.